The tumor suppressor gene CDKN2A (MTS1/p16), located on chromosome 9p21, is inactivated in a variety of tumors including melanomas and tumors of the biliary tract, pancreas, and stomach. The aim of the present study was to determine whether this gene is inactivated in hepatocellular carcinoma (HCC).
Frequent deletion of MTS1/p16 gene and correlation with clinicopathological parameters in endometrial carcinoma
β Scribed by Chunxiao Zhou; Jianheng Sun; Shixin Lu; Shunqian Jin; Hailing Liu; Xiugui Sheng
- Publisher
- Chinese Anti-Cancer Association
- Year
- 1998
- Tongue
- English
- Weight
- 326 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1000-9604
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The molecular mechanisms of hepatocarcinogenesis recent study on potential familial HCC in Alaskan natives are poorly understood. Only very recently has there excluded mutation of the p53 gene as the responsible genetic been a suggestion of familial hepatocellular carcinoma lesion. 1 This suggests t
To determine the relationship between p16 MTS1/CDK4I expression, gene inactivation and 9p21 loss of heterozygosity (LOH) in the development of laryngeal carcinomas, we have examined p16 MTS1/CDK4I protein and mRNA expression in a series of 7 normal and 36 tumoral tissues, and the presence of gene al